IP Verse

Methods To Mobilize Progenitor/Stem Cells - EP2371361B1

PatentPatent Analysis

EP2371361

GENZYME
Application Number
EP10184509A
Filing Date
Jul 30, 2002
Status
Revoked
Aug 10, 2024
Grant Date
Aug 7, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3137497B2
EP2976359B2
EP2970843B1

Bibliography

The patent EP2371361B1 was granted to Genzyme on Aug 7, 2019 following the initial filing on Jul 30, 2002 under the application number EP10184509A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (7)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ACCORD HEALTHCAREMay 7, 2020ADMISSIBLE
BETAPHARM ARZNEIMITTELMay 7, 2020ADMISSIBLE
SANDOZMay 7, 2020ADMISSIBLE
STADA ARZNEIMITTELMay 7, 2020ADMISSIBLE
ZENTIVAMay 7, 2020ADMISSIBLE
TEVA PHARMACEUTICALSMay 6, 2020ADMISSIBLE
GENERICS UK TRADING MYLANMay 4, 2020ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents